Quadrature Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,193
Closed -$668K 1425
2024
Q1
$668K Buy
9,193
+3,965
+76% +$265K 0.01% 604
2023
Q4
$320K Buy
+5,228
New +$310K 0.01% 834
2020
Q4
Sell
-7,232
Closed -$263K 1009
2020
Q3
$263K Buy
+7,232
New +$269K 0.02% 602
2018
Q2
Sell
-25,245
Closed -$851K 669
2018
Q1
$851K Buy
25,245
+14,766
+141% +$567K 0.07% 282
2017
Q4
$465K Buy
+10,479
New +$477K 0.04% 339
2017
Q2
Sell
-29,281
Closed -$1.63M 724
2017
Q1
$1.63M Buy
29,281
+20,050
+217% +$1.11M 0.12% 196
2016
Q4
$481K Sell
9,231
-18,967
-67% -$915K 0.03% 434
2016
Q3
$1.36M Buy
+28,198
New +$1.43M 0.12% 185

Other funds holding PBH

Quadrature Capital's PBH Position: Q2 2024 in Review

Quadrature Capital sold out of Prestige Consumer Healthcare (PBH) in Q2 2024, closing a stake of 9,193 shares — an estimated $668K sold.

Quadrature Capital first reported a position in PBH in Q3 2016 and held it in 8 quarters. The position peaked at $1.63M in Q1 2017. 306 funds tracked by Wall St. Rank hold PBH as of Q2 2024.

  • Quadrature Capital reported no remaining Prestige Consumer Healthcare position as of Q2 2024 after selling out during the quarter.
  • Quadrature Capital sold 9,193 Prestige Consumer Healthcare shares in Q2 2024, an estimated $668K.
  • Quadrature Capital first reported a position in Prestige Consumer Healthcare in Q3 2016 and held it in 8 quarters.
  • Quadrature Capital's Prestige Consumer Healthcare position peaked at $1.63M in Q1 2017.
  • 306 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2024.

Based on Quadrature Capital's 13F filing for Q2 2024, filed 14 Aug 2024.